^Casimir J, Jadot J, Renard M (1960). “Séparation et caractérisation de la N-éthyl-γ-glutamine à partir de Xerocomus badius”. Biochim. Biophys. Acta39: 462–468. doi:10.1016/0006-3002(60)90199-2. PMID13808157.
^ abYokogoshi H, Kobayashi M, Mochizuki M, Terashima T (1998). “Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats”. Neurochem. Res.23 (5): 667–73. doi:10.1023/A:1022490806093. PMID9566605.
^Gomez-Ramirez M; Higgins, BA; Rycroft, JA; Owen, GN; Mahoney, J; Shpaner, M; Foxe, JJ (2007). “The Deployment of Intersensory Selective Attention: A High-density Electrical Mapping Study of the Effects of Theanine”. Clin. Neuropharmacol.30 (1): 25–38. doi:10.1097/01.WNF.0000240940.13876.17. PMID17272967.
^Egashira N, Ishigami N, Pu F, et al. (2008). “Theanine prevents memory impairment induced by repeated cerebral ischemia in rats”. Phytother Res22 (1): 65–8. doi:10.1002/ptr.2261. PMID17705146.
^Kakuda T, Nozawa A, Sugimoto A, Niino H (2002). “Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors”. Biosci. Biotechnol. Biochem.66 (12): 2683-2686. doi:10.1271/bbb.66.2683. PMID12596867.
^ abNathan P, Lu K, Gray M, Oliver C (2006). “The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent”. J. Herb. Pharmacother.6 (2): 21–30. doi:10.1300/J157v06n02_02. PMID17182482.
^Yokogoshi H, Mochizuki M, Saitoh K (1998). “Theanine-induced reduction of brain serotonin concentration in rats”. Biosci. Biotechnol. Biochem.62 (4): 816-817. doi:10.1271/bbb.62.816. PMID9614715.
^Yokogoshi H, Kobayashi M, Mochizuki M, Terashima T. Effect of theanine, γ-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 1998;23(5):667-73.
^Borzelleca J, Peters D, Hall W (2006). “A 13-week dietary toxicity and toxicokinetic study with L-theanine in rats”. Food Chem Toxicol44 (7): 1158–66. doi:10.1016/j.fct.2006.03.014. PMID16759779.
^Ritsner, Michael S.; Miodownik, Chanoch; Ratner, Yael; Shleifer, Tatyana; Mar, Maria; Pintov, Leonid; Lerner, Vladimir (2011). “L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients with Schizophrenia and Schizoaffective Disorder”. The Journal of Clinical Psychiatry72 (1): 34–42. doi:10.4088/JCP.09m05324gre. PMID21208586.
^Haskell CF, Kennedy DO, Milne AL, Wesnes KA, Scholey AB (2008). “The effects of L-theanine, caffeine and their combination on cognition and mood”. Biol. Psychol.77 (2): 113–22. doi:10.1016/j.biopsycho.2007.09.008. PMID18006208.